278 related articles for article (PubMed ID: 17189721)
21. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ
J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of repression of squamous differentiation marker, SPRR1B, in malignant bronchial epithelial cells: role of critical TRE-sites and its transacting factors.
Patterson T; Vuong H; Liaw YS; Wu R; Kalvakolanu DV; Reddy SP
Oncogene; 2001 Feb; 20(5):634-44. PubMed ID: 11313996
[TBL] [Abstract][Full Text] [Related]
23. cFos is critical for MCF-7 breast cancer cell growth.
Lu C; Shen Q; DuPré E; Kim H; Hilsenbeck S; Brown PH
Oncogene; 2005 Sep; 24(43):6516-24. PubMed ID: 16027729
[TBL] [Abstract][Full Text] [Related]
24. Impaired AP-1 dimers and NFAT complex formation in immature thymocytes during in vivo glucocorticoid-induced apoptosis.
Wisniewska M; Pyrzynska B; Kaminska B
Cell Biol Int; 2004; 28(11):773-80. PubMed ID: 15563399
[TBL] [Abstract][Full Text] [Related]
25. Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway.
Huang H; Chang EJ; Ryu J; Lee ZH; Lee Y; Kim HH
Biochem Biophys Res Commun; 2006 Dec; 351(1):99-105. PubMed ID: 17052691
[TBL] [Abstract][Full Text] [Related]
26. Cross-family interaction between the bHLHZip USF and bZip Fra1 proteins results in down-regulation of AP1 activity.
Pognonec P; Boulukos KE; Aperlo C; Fujimoto M; Ariga H; Nomoto A; Kato H
Oncogene; 1997 May; 14(17):2091-8. PubMed ID: 9160889
[TBL] [Abstract][Full Text] [Related]
27. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts.
Wu JB; Fong YC; Tsai HY; Chen YF; Tsuzuki M; Tang CH
Eur J Pharmacol; 2008 Jul; 588(2-3):333-41. PubMed ID: 18495116
[TBL] [Abstract][Full Text] [Related]
28. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway.
Sato K; Suematsu A; Nakashima T; Takemoto-Kimura S; Aoki K; Morishita Y; Asahara H; Ohya K; Yamaguchi A; Takai T; Kodama T; Chatila TA; Bito H; Takayanagi H
Nat Med; 2006 Dec; 12(12):1410-6. PubMed ID: 17128269
[TBL] [Abstract][Full Text] [Related]
29. c-Fos degradation by the ubiquitin-proteasome proteolytic pathway in osteoclast progenitors.
Ito Y; Inoue D; Kido S; Matsumoto T
Bone; 2005 Dec; 37(6):842-9. PubMed ID: 16172035
[TBL] [Abstract][Full Text] [Related]
30. The mechanism of osteoclast differentiation induced by IL-1.
Kim JH; Jin HM; Kim K; Song I; Youn BU; Matsuo K; Kim N
J Immunol; 2009 Aug; 183(3):1862-70. PubMed ID: 19587010
[TBL] [Abstract][Full Text] [Related]
31. Jun signalling in the epidermis: From developmental defects to psoriasis and skin tumors.
Zenz R; Wagner EF
Int J Biochem Cell Biol; 2006; 38(7):1043-9. PubMed ID: 16423552
[TBL] [Abstract][Full Text] [Related]
32. Wnt-3a regulates chondrocyte differentiation via c-Jun/AP-1 pathway.
Hwang SG; Yu SS; Lee SW; Chun JS
FEBS Lett; 2005 Aug; 579(21):4837-42. PubMed ID: 16099458
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption.
Park CK; Kim HJ; Kwak HB; Lee TH; Bang MH; Kim CM; Lee Y; Chung DK; Baek NI; Kim J; Lee ZH; Kim HH
Int Immunopharmacol; 2007 Dec; 7(12):1507-16. PubMed ID: 17920527
[TBL] [Abstract][Full Text] [Related]
34. Eicosapentaenoic acid prevents lipopolysaccharide-stimulated DNA binding of activator protein-1 and c-Jun N-terminal kinase activity.
Zhao Y; Chen LH
J Nutr Biochem; 2005 Feb; 16(2):78-84. PubMed ID: 15681165
[TBL] [Abstract][Full Text] [Related]
35. MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability.
Cuevas BD; Uhlik MT; Garrington TP; Johnson GL
Oncogene; 2005 Jan; 24(5):801-9. PubMed ID: 15558021
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
[TBL] [Abstract][Full Text] [Related]
37. Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis.
van Dam H; Castellazzi M
Oncogene; 2001 Apr; 20(19):2453-64. PubMed ID: 11402340
[TBL] [Abstract][Full Text] [Related]
38. A mechanism of AP-1 suppression through interaction of c-Fos with lamin A/C.
Ivorra C; Kubicek M; González JM; Sanz-González SM; Alvarez-Barrientos A; O'Connor JE; Burke B; Andrés V
Genes Dev; 2006 Feb; 20(3):307-20. PubMed ID: 16452503
[TBL] [Abstract][Full Text] [Related]
39. EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways.
Kajanne R; Miettinen P; Mehlem A; Leivonen SK; Birrer M; Foschi M; Kähäri VM; Leppä S
J Cell Physiol; 2007 Aug; 212(2):489-97. PubMed ID: 17348021
[TBL] [Abstract][Full Text] [Related]
40. Impaired osteoclastogenesis by staphylococcal lipoteichoic acid through Toll-like receptor 2 with partial involvement of MyD88.
Yang J; Ryu YH; Yun CH; Han SH
J Leukoc Biol; 2009 Oct; 86(4):823-31. PubMed ID: 19602669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
